INO Competitors
Inovio Pharmaceuticals, Inc.
$0.99
-$0.05(-4.80%)
34
Overall
60
Value
10
Tech
34
Quality
Market Cap
$102.37M
Volume
2.06M
52W Range
$0.56 - $2.72
Target Price
$3.17
INO competitors: PFE, JNJ, ARWR, NVS, MRK. Inovio Pharmaceuticals, Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
INO Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| PFE Pfizer Inc. | $29.58 | $168.60B | $2.96 | 5.81% | 76 |
| JNJ Johnson & Johnson | $255.56 | $615.87B | $11.10 | 2.07% | 56 |
| ARWR Arrowhead Pharmaceuticals, Inc. | $55.90 | $7.90B | $-3.62 | - | 33 |
| NVS Novartis AG | $150.62 | $287.41B | $8.89 | 3.17% | 76 |
| MRK Merck & Co., Inc. | $145.95 | $360.08B | $2.66 | 2.33% | 77 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INO | $0.99 | -4.8% | 2.06M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Inovio Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW